NXGL — NEXGEL, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1468929 ·
Last close
$0.18
Market Cap
$1.74M
52W High
$2.89
52W Low
$0.16
ADV30
1,260,972
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 3,686,000 | 1,109,000 | -2,505,000 | -3,635,000 | 26,447,000 | 492,000 | 20,981,000 |
| Mar 2026 | 2,650,000 | 1,061,000 | -958,000 | -927,000 | 11,598,000 | 208,000 | 7,116,000 |
| Dec 2025 | 2,796,000 | 819,000 | -1,214,000 | -970,000 | 10,461,000 | 317,000 | 5,570,000 |
| Sep 2025 | 2,934,000 | 1,243,000 | -725,000 | -653,000 | 11,620,000 | 938,000 | 6,044,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,415,000
Investing CF
$-77,000
Financing CF
$2,422,000
CapEx
$-126,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.37
As of
2026-08-23
Balance + Analyst (yfinance extras)
Retained Earnings
$-21,923,000
Inventory
$2,263,000
Receivables
$662,000
ST Investments
—
EBIT TTM
$-3,099,000
Pretax Income TTM
$-3,086,000
Interest Exp TTM
$86,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$12,067,000
EBITDA
$-4,251,000
Free Cash Flow
$8,448,625
Enterprise Value
$10,320,545
Total Cash
$492,000
Total Debt
$7,458,000
Shares Out
9,747,663
Trailing EPS
$-0.74
Book Value
$0.51
ROE
-115.1%
ROA
-18.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 11,421,000 | -3,352,000 | -3,000,000 | 10,461,000 | 5,570,000 | 4,459,000 | -1,311,000 |
| Dec 2024 | 8,688,000 | -3,554,000 | -3,281,000 | 10,983,000 | 4,903,000 | 5,755,000 | -3,867,000 |
| Dec 2023 | 4,089,000 | -3,477,000 | -3,157,000 | 9,955,000 | 4,789,000 | 4,697,000 | -3,236,000 |
| Dec 2022 | 2,048,000 | -3,348,000 | -4,746,000 | 10,357,000 | 2,720,000 | 7,637,000 | -2,992,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.22
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CUPR | Cuprina Holdings (Cayman) LTD | $1.80M | $1.95 | — |
| YBGJ | Yubo International Biotech Ltd | $1.84M | $0.01 | — |
| TNON | Tenon Medical, Inc. | $1.91M | $2.86 | — |
| TUTH | Standard Dental Labs Inc. | $2.07M | $0.06 | — |
| GCTK | Glucotrack, Inc. | $1.44M | $1.80 | — |
News headlines (Yahoo Finance, 1h cache)
NEXGEL Announces Date for Investor Update Call
2026-09-16 13:29 · Yahoo
NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE
2026-08-20 20:05 · Yahoo
NEXGEL Q2 Revenue Reaches $3.69 Million as BioNX Integration Faces Slower Ramp
2026-08-17 14:54 · Yahoo
NEXGEL Reports Second Quarter 2026 Financial Results
2026-08-17 12:00 · Yahoo
NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th
2026-06-04 13:00 · Yahoo
Nexgel (NXGL) Q1 2026 Earnings Transcript
2026-05-15 16:54 · Yahoo
NEXGEL To Report First Quarter 2026 Financial Results on May 15th
2026-05-12 14:27 · Yahoo
NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors
2026-05-06 13:00 · Yahoo
NEXGEL Appoints Ian Blackman as Chief Financial Officer
2026-04-27 13:00 · Yahoo
NEXGEL, Inc. Q4 2025 Earnings Call Summary
2026-04-21 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.